
Medeia is a privately owned, venture capital backed company. Our investors include:
www.invenicapital.com
Inveni Capital, with offices in Finland and Germany, is a venture capital management company with some € 30 million under management. Inveni is investing in early to growth–stage life science (pharma and medtech) companies in Northern and Central Europe. Inveni’s experienced team is highly engaged in its portfolio companies. Inveni was the leading investor on Medeia’s second financing round in 2008.
Seed Fund Vera Ltd makes capital investments in innovative enterprises at their early stages. The fund is a subsidiary of Finnvera plc. Veraventure Ltd is responsible for Seed Fund’s management and practical activities.
Medeia Therapeutics Ltd has been awarded a 0,65 million euro grant from Young Innovative Company (YIC) program financed by Tekes.
Read more...
Medeia Therapeutics receives significant support from Finnish Funding Agency for Technology and Innovation (Tekes)
Read more...
Medeia Therapeutics announces the second financing round led by Inveni Capital
Read more...